ACTRN12619001043123进行中（未招募）2 期
Avatrombopag iN Relapsed or Refractory severe Aplastic Anaemia as EXtra Therapy – a Bayesian Optimal Phase II study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Refractory severe aplastic anaemia with an incomplete response following at least one course of horse or rabbit ATG given greater than 6 months ago. Incomplete response defined as any one of the following:
- •oAbsolute neutrophil count <0.5 x10^9/L
- •oPlatelet count <20 x 10^9/L
- •oAbsolute reticulocyte count <60 x 10^9/L or ongoing requirement for red cell transfusion support (if not due to independent medical condition)
- •Relapsed severe aplastic anaemia, defined as the occurrence of any of the following, after a haematological response to a prior course of horse or rabbit ATG given greater than 6 months ago:
- •meeting again the criteria for SAA
- •requirement for transfusion support (if not due to independent medical conditions)
- •decrease in any of the peripheral blood counts as follows
- •absolute neutrophils < 0.5 x 10^9/L
- •platelets <20 x 10^9/L
- •2. Age >18
- •3. Negative pregnancy test for women of child bearing potential
排除标准
- •1.Evidence of a myelodysplastic syndrome, defined according to the World Health Organization 2017 criteria. Patients with AA with cytogenetic abnormalities, which are recurrent in MDS, who do not meet the WHO diagnostic criteria for MDS, are also excluded. Patients with del (20q), +8 and –Y are not included in this category and are therefore eligible for this trial.
- •2.Known diagnosis or clinical suspicion of inherited bone marrow failure syndrome (IBMFS), including but not limited to Fanconi Anaemia, Dyskeratosis Congenita, Shwachman-Diamond Syndrome and Diamond-Blackfan Anaemia
- •3.Cancer diagnosis within the last 5 years (except for patients with resected basal cell carcinoma or squamous cell carcinoma of the skin)
- •4.Previous history of melanoma
- •5.Pregnant or breast feeding patients2
- •6.Participants with known hypersensitivity to avatrombopag
- •7.Severe renal impairment (defined as creatinine clearance =30m/min)
- •8.Treatment with horse or rabbit ATG within 6 months of trial entry. Concurrent treatment with Cyclosporine A is permitted.
- •9.Death anticipated within 14 days
研究者
相似试验
招募中
不适用
A phase II study of avelumab in relapsed or refractory stage III/IV extranodal natural killer/T-cell lymphomaNeoplasmsKCT0003206Samsung Medical Center33
进行中（未招募）
1 期
An open label, Aclasta, re-treatment of relapsed patients with Paget´s disease of bone who participated in the CZOL446K2304 and CZOL446K2305 Core Registration studies - NATreatment of Paget´s disease of the boneMedDRA version: 9.1Level: LLTClassification code 10033363Term: Paget's disease of boneEUCTR2008-002898-12-BEovartis Pharma Services AG30
进行中（未招募）
不适用
An open label, Aclasta, re-treatment of relapsed patients with Paget´s disease of bone who participated in the CZOL446K2304 and CZOL446K2305 Core Registration studies - NAEUCTR2008-002898-12-GBovartis Pharma Services AG30
已完成
不适用
Staying Well After Depression: a randomised trialRecurrent depressionMental and Behavioural DisordersDepressive episodeISRCTN97185214niversity of Oxford (UK)300
尚未招募
不适用
Comparing Vaginal And Laparoscopic Uterosacral Suspension For Pelvic Organ Prolapsepelvic organ prolapseSurgery - Surgical techniquesRenal and Urogenital - Other renal and urogenital disordersReproductive Health and Childbirth - Other reproductive health and childbirth disordersACTRN12621001246875Anna Rosamilia170